These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36570624)

  • 21. Normal- and Low-Luminance Automated Quantitative Contrast Sensitivity Assessment in Eyes With Age-Related Macular Degeneration.
    Ou WC; Lesmes LA; Christie AH; Denlar RA; Csaky KG
    Am J Ophthalmol; 2021 Jun; 226():148-155. PubMed ID: 33529583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anaphylatoxin Signaling in Retinal Pigment and Choroidal Endothelial Cells: Characteristics and Relevance to Age-Related Macular Degeneration.
    Rohrer B
    Adv Exp Med Biol; 2018; 1074():45-51. PubMed ID: 29721926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stem cell therapies for age-related macular degeneration: the past, present, and future.
    Dang Y; Zhang C; Zhu Y
    Clin Interv Aging; 2015; 10():255-64. PubMed ID: 25609937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stem cell based therapies for age-related macular degeneration: The promises and the challenges.
    Nazari H; Zhang L; Zhu D; Chader GJ; Falabella P; Stefanini F; Rowland T; Clegg DO; Kashani AH; Hinton DR; Humayun MS
    Prog Retin Eye Res; 2015 Sep; 48():1-39. PubMed ID: 26113213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stem cell-based therapies for age-related macular degeneration: current status and prospects.
    Mu Y; Zhao M; Su G
    Int J Clin Exp Med; 2014; 7(11):3843-52. PubMed ID: 25550892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Deep Phenotype Association Study Reveals Specific Phenotype Associations with Genetic Variants in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 (AREDS2) Report No. 14.
    van Asten F; Simmons M; Singhal A; Keenan TD; Ratnapriya R; Agrón E; Clemons TE; Swaroop A; Lu Z; Chew EY;
    Ophthalmology; 2018 Apr; 125(4):559-568. PubMed ID: 29096998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dry age-related macular degeneration: recent progress of therapeutic approaches.
    Kuno N; Fujii S
    Curr Mol Pharmacol; 2011 Nov; 4(3):196-232. PubMed ID: 21545354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What determines the switch between atrophic and neovascular forms of age related macular degeneration? - the role of BMP4 induced senescence.
    Zhu D; Deng X; Xu J; Hinton DR
    Aging (Albany NY); 2009 Aug; 1(8):740-5. PubMed ID: 20157553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatments for dry age-related macular degeneration and Stargardt disease: a systematic review.
    Waugh N; Loveman E; Colquitt J; Royle P; Yeong JL; Hoad G; Lois N
    Health Technol Assess; 2018 May; 22(27):1-168. PubMed ID: 29846169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient selection criteria for pilot studies on amelioration of non-neovascular age-related macular degeneration.
    Azuma M; Chung K; Fujii A; Shearer TR
    J Ocul Pharmacol Ther; 2010 Aug; 26(4):367-71. PubMed ID: 20653480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Single-Nucleotide Polymorphisms in Age-Related Macular Degeneration With Pseudodrusen: Secondary Analysis of Data From the Comparison of AMD Treatments Trials.
    Lin LY; Zhou Q; Hagstrom S; Maguire MG; Daniel E; Grunwald JE; Martin DF; Ying GS;
    JAMA Ophthalmol; 2018 Jun; 136(6):682-688. PubMed ID: 29801032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subthreshold Nanosecond Laser Intervention in Intermediate Age-Related Macular Degeneration: Study Design and Baseline Characteristics of the Laser in Early Stages of Age-Related Macular Degeneration Study (Report Number 1).
    Lek JJ; Brassington KH; Luu CD; Chen FK; Arnold JJ; Heriot WJ; Durkin SR; Chakravarthy U; Guymer RH;
    Ophthalmol Retina; 2017; 1(3):227-239. PubMed ID: 31047426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low luminance visual dysfunction as a predictor of subsequent visual acuity loss from geographic atrophy in age-related macular degeneration.
    Sunness JS; Rubin GS; Broman A; Applegate CA; Bressler NM; Hawkins BS
    Ophthalmology; 2008 Sep; 115(9):1480-8, 1488.e1-2. PubMed ID: 18486216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current therapeutic developments in atrophic age-related macular degeneration.
    Hanus J; Zhao F; Wang S
    Br J Ophthalmol; 2016 Jan; 100(1):122-7. PubMed ID: 26553922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Choriocapillaris changes in dry age-related macular degeneration and geographic atrophy: a review.
    Arya M; Sabrosa AS; Duker JS; Waheed NK
    Eye Vis (Lond); 2018; 5():22. PubMed ID: 30238015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Phenotypic Course of Age-Related Macular Degeneration for ARMS2/HTRA1: The EYE-RISK Consortium.
    Thee EF; Colijn JM; Cougnard-Grégoire A; Meester-Smoor MA; Verzijden T; Hoyng CB; Fauser S; Hense HW; Silva R; Creuzot-Garcher C; Ueffing M; Delcourt C; den Hollander AI; Klaver CCW;
    Ophthalmology; 2022 Jul; 129(7):752-764. PubMed ID: 35240203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beyond AREDS Formulations, What Is Next for Intermediate Age-Related Macular Degeneration (iAMD) Treatment? Potential Benefits of Antioxidant and Anti-inflammatory Apocarotenoids as Neuroprotectors.
    Camelo S; Latil M; Veillet S; Dilda PJ; Lafont R
    Oxid Med Cell Longev; 2020; 2020():4984927. PubMed ID: 33520083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imaging Features Associated with Progression to Geographic Atrophy in Age-Related Macular Degeneration: Classification of Atrophy Meeting Report 5.
    Jaffe GJ; Chakravarthy U; Freund KB; Guymer RH; Holz FG; Liakopoulos S; Monés JM; Rosenfeld PJ; Sadda SR; Sarraf D; Schmitz-Valckenberg S; Spaide RF; Staurenghi G; Tufail A; Curcio CA
    Ophthalmol Retina; 2021 Sep; 5(9):855-867. PubMed ID: 33348085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exacerbation of choroidal and retinal pigment epithelial atrophy after anti-vascular endothelial growth factor treatment in neovascular age-related macular degeneration.
    Young M; Chui L; Fallah N; Or C; Merkur AB; Kirker AW; Albiani DA; Forooghian F
    Retina; 2014 Jul; 34(7):1308-15. PubMed ID: 24451923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of retinal pigment epithelial tears after intravitreal ranibizumab injection for neovascular age-related macular degeneration.
    Cunningham ET; Feiner L; Chung C; Tuomi L; Ehrlich JS
    Ophthalmology; 2011 Dec; 118(12):2447-52. PubMed ID: 21872935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.